| Variable | Group | χ2 | df | p | |||
|---|---|---|---|---|---|---|---|
|
Intervention Freq. (%) n = 186 |
Control Freq. (%) n = 186 | ||||||
| Baseline | |||||||
| Reported ITN use | 7.434 | 4 | 0.115 | ||||
| Never | 113 | (60.8) | 99 | (53.2) | |||
| Seldom | 10 | (5.4) | 18 | (9.7) | |||
| Sometimes | 20 | (10.7) | 16 | (8.6) | |||
| Often | 26 | (14.0) | 23 | (12.4) | |||
| Almost always | 17 | (9.1) | 30 | (16.1) | |||
| 2 months | |||||||
| Reported ITN use | 27.974 | 4 | < 0.001 | ||||
| Never | 38 | (22.4) | 40 | (25.2) | |||
| Seldom | 11 | (6.5) | 38 | (23.9) | |||
| Sometimes | 32 | (18.8) | 32 | (20.1) | |||
| Often | 51 | (30.0) | 22 | (13.8) | |||
| Almost always | 38 | (22.4) | 27 | (17.0) | |||
| 4 months | |||||||
| Reported ITN use | 12.905 | 4 | 0.012 | ||||
| Never | 30 | (21.6) | 35 | (27.3) | |||
| Seldom | 8 | (5.8) | 22 | (17.2) | |||
| Sometimes | 28 | (20.1) | 24 | (18.8) | |||
| Often | 39 | (28.1) | 22 | (17.2) | |||
| Almost always | 34 | (24.5) | 25 | (19.5) | |||
| Baseline | |||||||
| Reported doses of IPTp taken | 0.275 | 1 | 0.600 | ||||
| Yes | 77 | (41.4) | 82 | (44.1) | |||
| No | 109 | (58.6) | 104 | (55.9) | |||
| 2 months | |||||||
| Reported doses of IPTp taken | 10.609 | 2 | 0.005 | ||||
| None | 24 | (14.1) | 40 | (25.2) | |||
| One | 103 | (60.6) | 97 | (61.0) | |||
| Two | 43 | (25.3) | 22 | (13.8) | |||
| 4 months | |||||||
| Reported doses of IPTp taken | 26.350 | 3 | < 0.001 | ||||
| None | 6 | (4.3) | 10 | (7.8) | |||
| One | 20 | (14.4) | 47 | (36.7) | |||
| Two | 82 | (59.0) | 62 | (48.4) | |||
| Three | 31 | (22.3) | 9 | (7.0) | |||